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Background. Limited research has been conducted on the moderating effect of race/ethnicity on objective sleep disturbances in
breast cancer survivors (BCSs). Objective. To explore racial/ethnic differences in objective sleep disturbances among BCSs and their
relationship with self-reported symptoms. Intervention/Methods. Sleep disturbance and symptoms were measured using actigraphy
for 72 hours and self-reported questionnaires, respectively, among 79 BCSs. Analysis of covariance, Pearson’s correlation, and
multivariate regression were used to analyze data. Results. Sixty (75.9%) participants listed their ethnicity as white, non-Hispanic
and 19 (24.1%) as minority. Total sleep time was 395.9 minutes for white BCSs compared to 330.4 minutes for minority BCSs.
Significant correlations were seen between sleep onset latency (SOL) and depression, SOL and fatigue, and sleep efficiency (SE) and
fatigue among minority BCSs. Among white BCSs, significant correlations were seen between SE and pain and wake after sleep
onset (WASO) and pain. The association between depression and SOL and fatigue and SOL appeared to be stronger in minority
BCSs than white BCSs. Conclusions. Results indicate that white BCSs slept longer than minority BCSs, and race/ethnicity modified
the effect of depression and fatigue on SOL, respectively. Implications for Practice. As part of survivorship care, race/ethnicity should
be included as an essential component of comprehensive symptom assessments.

1. Introduction
Breast cancer is the second most commonly diagnosed cancer
in the United States and comprises the largest population
of cancer survivors, estimated at 2.9 million women and
accounting for 22% of all cancer survivors [1]. Advances
in breast cancer screening, diagnosis, and treatment have
substantially increased the number of breast cancer survivors
(BCSs) and with this have highlighted the importance of
survivorship needs. A major concern among BCSs is sleep
disturbances. BCSs complain of sleep disturbances before,
during, and after the completion of treatment negatively
affecting their functional status and quality of life [2, 3].

Past research indicates that the prevalence of sleep disturbances in BCSs is 20% higher in comparison to the general
population and 32% higher in comparison to patients with
gastrointestinal cancer [4, 5]. With the increasing prevalence
of sleep disturbances, a standardized assessment to collect
and analyze data on sleep is becoming increasingly vital.
Previous studies have evaluated the association between
symptoms and objective sleep disturbances in patients with
breast cancer [6, 7]. These studies have focused primarily
on Caucasian women undergoing treatment with limited
research among racial/ethnic minorities [8, 9]. Therefore,
the goal of this study was to explore the moderating effect
of race/ethnicity on objective sleep disturbances and their
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Figure 1: Conceptual framework of the study. The symptom experience was the perception and evaluation of physical and psychological
symptoms; the outcome was objective sleep disturbances. This model tested whether the person domain, specifically the demographic variable
of race/ethnicity, modified the relationship between the dimensions of symptom experience and outcomes. BPI: Brief Pain Inventory Short
Form; CES-D: Center for Epidemiological Studies Depression Scale; FSI: Fatigue Symptom Inventory; SMM: Symptom Management Model;
STAI-S: State Trait Anxiety Inventory-State Scale only. Adapted from Humphreys et al. [11].

relationships with physical (i.e., pain and fatigue) and psychological symptoms (i.e., depression and anxiety) among BCSs,
who have completed treatment. The specific aims guiding this
paper were to (1) explore racial/ethnic differences in sleep
actigraphy parameters among BCSs, (2) explore racial/ethnic
differences in the associations between sleep actigraphy
parameters with physical (i.e., pain and fatigue) and psychological symptoms (i.e., depression and anxiety), and (3)
explore whether these relationships (between objective sleep
and self-reported symptoms) are modified by race/ethnicity.

2. Conceptual Framework
The conceptual framework for this study (Figure 1) was
based on the University of San Francisco School of Nursing Symptom Management Model (SMM) [10]. The SMM
illustrates that symptom management is a multidimensional
process, which is influenced by the nursing domains of
person, health/illness, or environment. The three domains
of nursing directly and indirectly impact three dimensions
of this model, which include symptom experience, symptom
management, and outcomes. Symptom experience is defined
as the perception, evaluation, and response to a change
in one’s usual feeling. Symptom management is a dynamic
process with efforts to avert, delay, or minimize the symptom
experience [11]. Lastly, outcomes are the consequences of the
symptom experience and management strategies.
The SMM is useful for this study of BCSs as sleep
disturbances are often presented with other symptoms, such
as depression, fatigue, and pain [12]; the SMM dimension
of symptom experience takes this into consideration. The
symptom experience was the perception and evaluation

of study participants’ physical (i.e., pain and fatigue) and
psychological symptoms (i.e., depression and anxiety) [11].
This experience could vary by BCS age, family history of
cancer, and race/ethnicity (person domain), cultural beliefs
(environmental domain), and comorbidities, stage of cancer, and type of adjuvant cancer treatment (health/illness
domain). The outcome of interest was objective sleep disturbances. Rather than the person domain influencing these
dimensions, the proposed model further expanded the SMM
by testing whether the person domain, specifically the demographic variable of race/ethnicity, modified the relationship
between the dimensions of symptom experience and outcomes.

3. Literature Review
Sleep disturbances are increasingly recognized as a side effect
of cancer treatment, affecting both physiological functioning
and psychological functioning. According to the American
Academy of Sleep Medicine [13], sleep disturbances are
characterized by difficulty in falling asleep or staying asleep,
early morning awakenings, nonrestorative sleep, and daytime sleepiness. Estimates of sleep disturbances vary widely,
ranging from 20% to 70% of newly diagnosed or recently
treated breast cancer patients, which is twice that found in
the general population [14]. Sleep disturbances can persist
through treatment and survivorship and are associated with
increased physical and psychological symptoms [15].
Epidemiologic studies have shown the importance of
sleep disturbances and race/ethnicity as predictors of health
and mortality risks [16]. Results from the National Health
Interview Study (NHIS) suggested that black ethnicity was
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a significant predictor of extreme sleep duration (≤5 hours
and ≥9 hours). Compared to whites, blacks were less likely
to report sleeping for 7 hours. Extreme sleep durations,
decreased sleep efficiency, and increased sleep disruptions
are commonly associated with comorbidities, early mortality,
and poor health among minority women and women with
advanced breast cancer [16, 17]. Increased knowledge of the
factors associated with sleep disturbances, including the effect
of race/ethnicity on sleep disturbances and their association
with symptoms, may improve our understanding of the
survivorship experience for patients with cancer.
Past research has indicated that minorities were more
likely to experience short sleep durations, lower sleep efficiency, and decreased deep wave sleep [18, 19]. Minority BCSs
commonly report sleep-related problems that include sleep
maintenance (36%), dissatisfaction with sleep (35.3%), difficulty in falling asleep (23.5%), and early morning awakenings
(22.4%) [20]. For patients receiving chemotherapy, whites
reported more sleep disturbances than black patients [21]. For
patients who have completed treatment, blacks were 44% less
likely to report sleep disturbances than whites [22]. The reason for these differences in sleep disturbances is questionable
and may be explained either by actual biological differences
or by a response bias to questionnaires [23]. Research suggests
that an inflammation pathway may mediate the association
between decreased sleep duration and cardiometabolic diseases, and this pathway may vary in blacks and whites [24, 25].
Response bias refers to positive reframing, repressive coping,
or the modification of responses to sleep questionnaires to
be perceived as socially desirable [23]. Blacks may cope with
sleep problems within a positive self-regulatory framework,
allowing them to deal more effectively with sleep-interfering
psychological processes and not perceive sleep disturbances
as stressful as other races/ethnicities [26].
Prior research suggests that racial/ethnic disparities exist
in the prevalence of symptoms among cancer survivors. In a
survey of 139 BCSs, fatigue (76%) was the most commonly
reported symptom followed by muscle aches (40%) [27].
Most BCSs complained of greater than six symptoms, and
Hispanic women were more likely to report chemotherapyrelated symptoms and pain-related symptoms compared
to white BCSs. In another study of 199 cancer survivors,
black cancer survivors experienced more pain interference,
severity, and disability compared to whites [28]. Black BCSs
were more likely to have chemotherapy and less likely to have
surgery compared to whites. Pain associated with cancer may
be associated with an increased morbidity and diminished
quality of life for black women consistent with an unequal
burden of cancer, pain, and cancer-related chronic pain [28].
Physical symptoms of pain and fatigue commonly cooccur with sleep disturbances. BCSs with fatigue showed
significant differences in total sleep time (TST) and wake
episodes compared to BCSs without fatigue [29]. Fatigued
BCSs also reported worse QOL [30]. In addition, increased
pain intensity over time significantly predicted sleep onset
latency (SOL) in BCSs [31]. Sleep efficiency (SE) was also
significantly lower for BCSs with pain [6]. The night before
breast-conserving surgery, BCSs with low SE reported significantly more postoperative pain than BCSs with high SE.
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Depression and anxiety are also frequently reported by
BCSs. In one study [32] of 67 BCSs, depressed mood significantly predicted subjective sleep quality but not objective
sleep in BCSs. Depressive symptoms also have been positively
correlated with the prevalence and severity of subjective sleep
in BCSs [33]. Anxiety has been correlated with subjective
sleep [34], with worse sleep being significantly correlated
with increased levels of anxiety in cancer patients. Previous
work has demonstrated that black BCSs were less anxious in
comparison to white BCSs [35]; this may be associated with
higher social support, improved spirituality, and decreased
fear of recurrence in black BCSs [36, 37].
We have limited insight on the effect of race/ethnicity
on objective sleep disturbances (i.e., sleep actigraphy) and
their association with physical and psychological symptoms.
The existing gaps in our knowledge point to a need for
additional research in this area. Therefore, the purposes of
this study were to explore racial/ethnic differences in objective sleep disturbances among BCSs, explore racial/ethnic
differences in the associations between objective sleep disturbances with symptoms, and explore the moderating effect
of race/ethnicity on the relationship between objective sleep
disturbances and symptoms.

4. Method
4.1. Design and Sample. A cross-sectional research design
was used to conduct a secondary data analysis of data from
the National Cancer Institute (NCI) administrative sleep
supplement study of the MBSR Symptom Cluster Trial for
Breast Cancer Survivors/1R01CA131080. Within the larger
study of 322 BCSs, a subsample of 79 completed baseline
actigraphic monitoring. Inclusion criterions for the parent
study were (1) female gender, age of 21 or older; (2) being
diagnosed with stage 0, I, II, or III breast cancer; (3) having
completed lumpectomy and/or mastectomy; (4) having from
two weeks to two years from the end of treatment with
adjuvant radiation and/or chemotherapy; (5) being able to
read and speak English at the 8th grade level or above; and (6)
having completed baseline actigraphic monitoring and selfreported questionnaires. Exclusion criteria consisted of (1)
female gender, with advanced stage breast cancer (stage IV);
(2) current diagnosis of severe current psychiatric disorder,
and (3) having undergone recurrent treatment for prior breast
cancer.
4.2. Setting. Participants were recruited from the H. Lee
Moffitt Cancer Center and Research Institute and the Carol
and Frank Morsani Center for Advanced Health Care located
in Tampa, Florida. Participants enrolled in the study and
completed baseline questionnaires in the Survivorship Clinic
of the Moffitt Research Center.
4.3. Procedures. The study protocol was approved by the
Institutional Review Board at the University of South Florida.
A research assistant approached eligible BCSs prior to
their scheduled appointment times; if patients were interested, they were invited to an orientation assessment where
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informed consent was obtained; they then completed baseline
assessment of pain, fatigue, depression, and anxiety through
self-reported questionnaires. After the completion of questionnaires, an actigraph was placed on the nondominant wrist
of each participant. Participants were asked to continuously
wear the actigraph for 72 hours and were provided with safety
and care instructions. Participants were also provided with
a prestamped, preaddressed envelope for the return of the
actigraphy bracelet after 72 hours.
4.4. Instruments. All participants completed questionnaires
presented in paper format. A demographic questionnaire
queried participants’ socioeconomic data including age,
race/ethnicity, religion, education, marital status, employment status, and income. Participants completed a clinical
history form for data including cancer diagnosis, cancer stage
at time of diagnosis, type of breast cancer, length of time
since cancer diagnosis, treatment type, and number of weeks
on radiation/chemotherapy. Clinical history was verified by
medical record review.
Objective sleep disturbances were measured by the Actiwatch Score actigraph (Philips Respironics, Andover, MA),
which is a noninvasive method that uses internal motion
sensors to capture patient movement data, represented as
the number of accelerations per minute [38]. Spans without
accelerometer movements reflect sleep. This data is then analyzed to produce a report containing parameters of sleep and
wake periods, along with their timing, duration, and other
characteristic details. Actigraphy scores correlated with EEG
sleep/wake status 95% of the time and with polysomnography
(PSG) within a range of ten percent [39].
Sleep disturbance was assessed using (1) SE, (2) SOL, (3)
TST, and (4) wake after sleep onset (WASO). SE is defined
as the percentage of time in bed spent sleeping [40]. It is
calculated by dividing the number of minutes of sleep by
the number of minutes in bed, multiplied by 100. SOL is the
duration of time from bedtime to falling asleep [40]. TST
is defined as the number of minutes of sleep while in bed
[40]. WASO refers to the number of minutes awake after sleep
onset during the sleep period [40]. All these parameters were
measured in this study.
The Fatigue Symptom Inventory (FSI) is a 14-item selfreport measure that is designed to assess severity, frequency,
daily pattern of fatigue, and perceived interference with QOL
[41]. Severity is measured on an 11-point scale (0: not at all; 10:
extreme fatigue). Convergent validity and divergent validity
were demonstrated with use of correlations with the fatigue
scale of the Profile of Mood States Fatigue and the Short-Form
General Health Survey (SF-36) vitality subscale [42]. The
internal consistency reliability of the four-item FSI severity
index in this study was alpha = 0.90.
Pain was measured by the Brief Pain Inventory (BPI)
Short Form,which consists of 9 items that measure the
severity of pain, impact of pain on daily function, location
of pain, pain medications, and amount of pain relief in the
past 24 hours or the past week [43]. The mean of the four
severity items is used as a measure of pain severity, and the
mean of the seven interference items is used as a measure of
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pain interference. The internal consistency reliability of the
four-item BPI severity scale in this study was alpha = 0.94.
The Center for Epidemiological Studies Depression Scale
(CES-D), used to measure depression, is a 20-item instrument that employs a 4-point scale (0: less than 1 day; 3:
5–7 days) to rate how frequently depressive symptoms were
experienced during the past week [44]. Measures include
cognitive, affective, behavioral, and somatic symptoms of
depression and positive effect. The internal consistency reliability of the CES-D in this study was alpha = 0.91. Scores range
from 0 to 60 with higher calculated scores indicative of more
severe depressive symptoms.
Anxiety was measured with use of the State Trait Anxiety
Inventory-State Scale only (STAI-S), a 20-item Likert scale
that measures state anxiety ranging from 1 (almost never) to
4 (almost always) [45]. The STAI-S measures an individual’s
transitional emotional response, including worry, nervousness, tension, and feelings of apprehension to a stressful
situation. The internal consistency reliability of the STAI-S in
this study was alpha = 0.94. Total scores range from 20 to 80,
with higher scores indicative of greater anxiety.

5. Data Analysis
Statistical Product and Services Solutions (SPSS) version
21.0 was utilized for all the deidentified data entry, data
management, and analysis for this study. Frequency distributions and descriptive statistics were used to describe
the sample demographic and clinical characteristics and
actigraphy parameters. 𝑡-test and chi square analysis were
used to compare sample demographic and clinical variables
between the white, non-Hispanic, and the minority BCSs.
Data analysis was conducted with a two-sided 𝑃 value of less
than 0.05 to define statistical significance. All demographic
and clinical variables with a 𝑃 value less than 0.05 were
included as potential covariates for this analysis. Age was
the only variable that was significantly (𝑃 = .041) different
between the two groups and was included as a potential
covariate for further analysis. Log transformation was completed to adjust for the skewness of data.
First, race/ethnicity was used to predict actigraphy
parameters. The predictor of interest was race/ethnicity (i.e.,
white, non-Hispanic versus other races/ethnicities) and the
defined outcome measures were SE, SOL, TST, and WASO.
Analysis of variance (ANOVA) was used initially to compare unadjusted means of the defined outcome variables
between the different racial groups, whereas analysis of
covariance (ANCOVA) was used to compare adjusted means.
The ANCOVA models were adjusted for age, which was
a covariate that was imbalanced between the two groups.
Secondly, to explore racial/ethnic differences in the associations between actigraphy parameters with physical and
psychological symptoms, Pearson correlations were calculated for continuous variables and 𝑡-tests for variables with
two categories. Significant correlations were further analyzed
using multiple linear regression analysis with the actigraphy
parameter as the dependent variable, race/ethnicity and
symptoms as main effect terms, and an interaction term
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Table 1: Surgery type, treatment type, stage of cancer, type of breast cancer, and time since completion of treatment of participants by
race/ethnicity (𝑁 = 79).
Variable
Surgery type, 𝑛 (%)
Lumpectomy
Mastectomy
Treatment type, 𝑛 (%)
Chemotherapy
Radiation
Chemotherapy and radiation
Surgery only
Cancer stage, 𝑛 (%)
0
1
2
3
Type of breast cancer, 𝑛 (%)
Ductal carcinoma in situ
Invasive lobular
Invasive ductal
Not specified
Unknown
Time since completion of treatment, 𝑛 (%)
2 weeks to 1 year
1 year to 2 years

Total
𝑛 = 79

White, non-Hispanic
𝑛 = 60

Minority
𝑛 = 19

34 (43.1)
45 (56.9)

25 (41.7)
35 (58.3)

9 (47.4)
10 (52.6)

10 (12.7)
21 (26.6)
23 (29.1)
25 (31.6)

7 (11.7)
15 (25.0)
16 (26.7)
22 (36.7)

3 (15.8)
6 (31.6)
7 (36.8)
3 (15.8)

13 (16.5)
27 (34.2)
27 (34.2)
12 (15.2)

9 (15.0)
21 (35.0)
20 (33.3)
10 (16.7)

4 (21.1)
6 (31.6)
7 (36.8)
2 (10.5)

13 (16.5)
26 (32.9)
22 (27.8)
3 (3.8)
15 (19.0)

9 (15.0)
20 (33.3)
18 (30.0)
1 (1.7)
12 (20.0)

4 (21.1)
6 (31.6)
4 (21.1)
2 (10.5)
3 (15.7)

𝑃 value
0.662

0.403

0.854

0.416

0.462
42 (53.2)
37 (46.8)

for physical or psychological symptom by race/ethnicity.
Separate models were created for each actigraphy parameter.
Simultaneous entry was used to enter independent variables
in the regression model as the goal was to specifically explore
the main effects of physical/psychological symptoms and
race/ethnicity, respectively, compared to the interaction effect
of physical/psychological symptoms with race/ethnicity on
actigraphy parameters.

6. Findings
6.1. Sample Demographics. Of the 79 participants, one participant was a nightshift worker and her actigraphy data was
not comparable to the sample and removed from the analysis;
however, her remaining data was included. The racial/ethnic
mix of the 79 participants was as follows: 60 (75.9%) white,
non-Hispanic; 7 (8.9%) white, Hispanic; 8 (10.1%) black, nonHispanic; 3 (3.8%) black, Hispanic; and 1 (1.3%) listed their
ethnicity as other. The mean age of the sample was 55.5 (SD
= 9.6) years with a mean age of 58.5 (SD = 8.6) years for
white, non-Hispanic BCSs and 52.4 (SD = 11.3) years for
minority BCSs. Table 1 shows the treatment related factors
for participants. The clinical variables listed in Table 1 were
not statistically different by race/ethnicity (𝑃 > 0.05). Table 2
displays the results summary of actigraphy parameters and
physical and psychological symptoms. TST was significantly
(𝑃 = 0.039) different between the groups with a greater

31 (51.7)
29 (48.3)

11 (57.9)
8 (42.1)

percentage of minority BCSs experiencing TST outside
the population norm [13] compared to the white, nonHispanic group. Though not significantly different, more
minority BCSs also experienced SOL and SE outside the
population norm and reported higher anxiety, pain, and
depression scores.
6.2. Racial/Ethnic Differences in Actigraphy Parameters. The
means, standard deviations, mean differences, lower limit,
upper limit, 𝑃 values, and adjusted 𝑃 values (with age as a
covariate) of the actigraphy parameters for the white, nonHispanic group were compared to those for the minority
group (Table 3). Results suggest that TST was significantly
higher for white, non-Hispanic participants (395.9 minutes)
than for minority participants (330.4 minutes) (𝑃 = 0.01).
In addition, minority participants took 35.7 minutes to fall
asleep compared to 22.5 minutes for the white, non-Hispanic
women (𝑃 = 0.07). Another nonsignificant trend for SE to
be higher in white, non-Hispanic women (80%) compared to
minority women (76%) (𝑃 = 0.09) was observed.
6.3. Relationship between Actigraphy Parameters and Symptoms. Correlations between the actigraphy parameters and
subjective measures of depression (CES-D), fatigue (FSI),
pain (BPI), and anxiety (STAI) for the white, non-Hispanic
group were compared to those for the minority group
(Table 4). Among minority BCSs, significant correlations
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Table 2: Descriptive statistics of actigraphy parameters, physical and psychological symptoms of participants by race/ethnicity (𝑁 = 78).

Variables Minimum
TST
SOL
SE
WASO
STAI
BPI
FSI
CES-D

234
0
56
11
20
0
0
0

Maximum

Mean

SD

Population normal

Percentage abnormal
(white)

Percentage abnormal
(minority)

𝑃 value

582
122
91
144
78
8.75
9
55

380.8
25.57
78.76
61.97
37.55
2.54
4.03
14.94

62.64
26.13
7.66
28.11
11.45
2.28
1.89
10.41

420–540 [13]a
<20 [13]a
>85 [13]a
<42 [13]a
<32.2 [45]b
<7 [43]c
≤3 [41]d
<16 [44]e

63.33
48.33
76.67
83.33
56.67
5.00
60.00
36.67

94.44
61.11
83.33
66.67
77.78
11.11
38.89
38.89

0.039∗
0.714
0.301
0.267
0.365
0.187
0.922
0.863

BPI: Brief Pain Inventory Short Form Severity Scale; CES-D: Center for Epidemiological Studies Depression Scale; FSI: Fatigue Symptom Inventory Severity
Scale; SE: sleep efficiency; SOL, sleep onset latency; STAI-S: State Trait Anxiety Inventory-State Scale only; TST: total sleep time; WASO: wake after sleep onset.
Data from the a American Academy of Sleep Medicine [13]; b Spielberger et al. [45]; c Cleeland [43]; d Hann et al. [41]; e Radloff [44].
∗
Variable is significant at the 0.05 level.

Table 3: Means, standard deviations, mean differences, lower and upper limits, and significance of actigraphy parameters of participants by
race/ethnicity (𝑁 = 78).
Actigraphy
parameter

Group

𝑛

Mean

Standard deviation

Mean difference

Lower limit

Upper limit

𝑃 value

Adjusted 𝑃 value

TST

Minority
White

18
60

330.39
395.92

57.47
56.22

−65.53
−65.53

301.81
381.39

358.97
410.44

0.01

0.01∗

SOL

Minority
White

18
60

35.69
22.53

31.61
23.71

13.15
13.15

19.97
16.41

51.44
28.66

0.12

0.07

SE

Minority
White

18
60

75.93
79.61

8.59
7.22

−3.68
−3.68

71.66
77.75

80.21
81.48

0.07

0.09

WASO

Minority
White

18
60

56.22
63.69

26.19
28.65

−7.48
−7.48

43.21
56.33

69.25
71.11

0.33

0.39

SE: sleep efficiency; SOL: sleep onset latency; TST: total sleep time; WASO: wake after sleep onset.
∗
Actigraphy parameter is significant at the 0.05 level.

were seen between SOL and depression (𝑟 = 0.453, 𝑃 =
0.049), SOL and fatigue (𝑟 = 0.517, 𝑃 = 0.028), and SE and
fatigue (𝑟 = −0.535, 𝑃 = 0.022). Among white, non-Hispanic
BCSs, significant correlations were seen between SE and pain
(𝑟 = −0.316, 𝑃 = 0.014) and WASO and pain (𝑟 = 0.367,
𝑃 = 0.040). No significant correlations were seen between
anxiety and actigraphy parameters.
6.4. Race/Ethnicity, Actigraphy Parameters, and Symptoms.
Table 5 displays the results of the multiple regression analyses
for SOL with depression and fatigue, respectively, SE with
fatigue and pain, respectively, and WASO with pain. In terms
of main effects, pain (𝑃 = 0.017) had a significant effect on
WASO. No main effects of depression or fatigue were found
on actigraphy parameters. Race/ethnicity (𝑃 = 0.056) had
a significant main effect on SE only. There was a significant
interaction (𝛽 = 0.502, 𝑃 = 0.046) between depression
and race/ethnicity on their effect on SOL and a significant
interaction (𝛽 = 0.596, 𝑃 = 0.033) between fatigue and
race/ethnicity on their effect on SOL.

7. Discussion
To our knowledge, this study is the first to explore
racial/ethnic differences in actigraphy parameters and the
moderating effect of race/ethnicity on the association
between actigraphy parameters and self-reported symptoms among BCSs. The current study yielded three main
findings. First, actigraphy parameters indicated that white,
non-Hispanic BCSs had better objective sleep compared to
minority BCSs. Second, there was evidence of differential
associations between symptoms and actigraphy parameters
by race/ethnicity. Third, race/ethnicity modified the effect of
depression and fatigue on SOL, respectively.
The first aim was to explore racial/ethnic differences
in actigraphy parameters among BCSs. Of the actigraphy
parameters, TST was significantly (𝑃 = 0.01) different
between the groups with minority BCSs having a lower TST
compared to white, non-Hispanic BCSs. Approximately 94%
of the minority group had TST outside the accepted range
compared to 63% of the white, non-Hispanic group. The
National Sleep Foundation [46] poll indicated that blacks
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Table 4: Correlations between sleep actigraphy parameters and depression, fatigue, pain, and anxiety (𝑁 = 78).
Actigraphy parameter
TST
SOL
SE
WASO

Group
Minority
White
Minority
White
Minority
White
Minority
White

𝑛
18
60
18
60
18
60
18
60

Depression
0.014
0.013
0.453∗
0.160
−0.361
−0.178
0.273
0.163

Fatigue
−0.277
−0.129
0.517∗
0.243
−0.535∗
−0.106
0.340
0.111

Pain
0.236
0.065
0.203
0.114
−0.092
−0.316∗
0.048
0.367∗

Anxiety
0.423
0.029
0.281
0.081
−0.107
−0.066
0.199
0.143

SE: sleep efficiency; SOL: sleep onset latency; TST: total sleep time; WASO: wake after sleep onset.
∗
Correlations are significant at the 0.05 level.

Table 5: Multiple regression analysis of race/ethnicity and symptoms in relation to sleep actigraphy parameters (𝑁 = 78).
Dependent
variable
SOL
(minutes)

Primary predictors
Race/ethnicity
Depression
Depression by race/ethnicity

Unstandardized coefficient Standardized coefficients
𝛽
𝑏
Std. error
−2.72
−0.262
0.617

5.22
0.505
0.304

−0.091
−0.104
0.502

𝑇

𝑃 value Adjusted 𝑅 squared

−0.522 0.603
−0.519 0.605
2.03 0.046∗
0.110

SOL
(minutes)

Race/ethnicity
Fatigue
Fatigue by race/ethnicity

−6.44
−2.69
3.39

6.65
2.81
1.57

−0.216
−0.195
0.596

−0.968 0.336
−0.959 0.341
2.17 0.033∗

SE
(percent)

Race/ethnicity
Fatigue
Fatigue by race/ethnicity

0.722
0.280
−0.774

1.94
0.819
0.456

0.082
0.069
−0.463

0.372
0.342
−1.70

0.711
0.733
0.094

SE
(percent)

Race/ethnicity
Pain
Pain by race/ethnicity

1.35
0.717
0.410

−0.299
−0.339
0.177

−1.94
−1.59
0.727

0.056∗
0.117
0.469

0.090

0.101
−2.62
−1.14
−0.298

0.064
WASO
(minutes)

Race/ethnicity
Pain
Pain by race/ethnicity

2.89
6.43
−1.98

4.95
2.64
1.51

0.090
0.522
−0.322

0.585
2.44
−1.32

0.560
0.017∗
0.192
0.064

SE: sleep efficiency; SOL: sleep-onset latency; WASO: wake after sleep onset.
∗
Correlations are significant at the 0.05 level.

reported the least amount of sleep, averaging 38 min less sleep
than whites. Lower levels of education, increased depressive
symptoms, and higher body mass index were associated
with short sleep durations of less than 420 minutes [47].
Recent evidence also suggests that residential environment
may influence racial/ethnic differences in sleep duration [9].
In addition, there was a trend for SOL to be longer
in minority BCSs compared to white, non-Hispanic BCSs.
Though not significantly different, 61% of minority BCSs
experienced prolonged SOL compared to 48% of white,
non-Hispanic BCSs. Furthermore, a greater percentage of
minority BCSs experienced decreased SE. These findings can
be compared to previous studies that showed blacks slept

for a shorter duration, took longer to fall asleep, and had
lower sleep efficiency compared to whites [18, 48]. A recent
meta-analysis also indicated similar findings with differences
mediated by factors such as adiposity, mental illness, and
employment status [49].
The second aim was to explore racial/ethnic differences
in the relationships between actigraphy parameters with
physical and psychological symptoms. Results suggest that
these associations may differ between white, non-Hispanics
and minorities. Specifically, depression was directly associated with SOL among minority BCSs; fatigue was directly
associated with SOL and inversely associated with SE among
minority BCSs; and pain was inversely associated with SE
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and directly associated with WASO among white BCSs
only. Previous investigators evaluated relationships between
symptoms and subjective sleep quality only. The magnitude of
the correlations between sleep and fatigue, depression, pain,
and anxiety ranged from 0.340 to 0.450, respectively, across
seven studies [6, 50, 51]. Contrary to prior findings, TST was
not associated with depression or fatigue [15].
The third aim was to explore the moderating effect
of race/ethnicity on the relationships between actigraphy
parameters and self-reported symptoms. There was no statistically significant effect of race/ethnicity, depression, or
fatigue on SOL. However, the combination of depression
by race/ethnicity and fatigue by race/ethnicity significantly
predicted SOL suggesting that race/ethnicity modified the
relationship of depression and fatigue on SOL. This indicates
that minority BCSs who are depressed or fatigued may benefit
from additional screening to determine if they are experiencing sleep disturbances. Fatigue, depression, and sleep
disturbances are the most commonly reported symptoms
by minority cancer survivors and often present together as
symptom clusters in BCSs [12, 20, 52]. Special consideration should be given to minority BCSs who present with
fatigue and depressive symptoms as these symptoms are often
underrecognized and undertreated in minority BCSs [20, 53].
Minority cancer survivors showed a reluctance to use the
word “depression,” making it more important for providers
to assess depression in this population [54]. Several factors
may contribute to increased depression in minority BCSs
including increased financial barriers, lower social status,
and decreased access to mental health services [53]. Cancerrelated health worries are also a significant predictor of both
depression and anxiety in black BCSs [55]. Early detection
and assessment of these symptoms are essential to decrease
sleep disturbances among BCSs.
Although race/ethnicity did not modify the effect of
fatigue on SE and pain on SE and WASO, respectively, it
was helpful in identifying symptoms that were perceived to
contribute to sleep disturbances among BCSs. Pain had a
significant main effect on WASO and an insignificant main
effect on SE. A previous study reported a strong correlation
between SE and pain severity among BCSs [6]. Consistent
with previous findings, pain was most commonly associated
with sleep disturbances among BCSs [56]. Race/ethnicity
also had a significant main effect on SE. Past research has
indicated that blacks have poorer sleep efficiency compared
to whites [16, 49].
7.1. Limitations. Due to the small sample size and imbalanced
number of racial/ethnic participants, there may be an underestimation of the strength of a true statistical association (i.e.,
type II error) or alternatively an overestimation of the effect
size and the possibility of type I error. Second, adjustments
for multiple comparisons were not completed due to the
exploratory nature of the study. Third, the cross-sectional
design of the study did not allow for causal relationships
between variables to be determined. Of the 79 participants,
there were 19 minority patients in the study which represented both blacks and Hispanics. These two groups may
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differ in regard to sleep patterns. Future studies should
incorporate larger samples of blacks and Hispanics with an
attempt to look at differences in sleep patterns between these
two groups. Finally, factors that may be associated with differences in actigraphy parameters between races/ethnicities
should also be considered. These include demographic risk
factors (educational status, employment status, and marital
status), clinical factors (medical comorbidities, medications
used to treat comorbidities, and the use of sleeping pills),
and lifestyle factors (alcohol/cigarette consumption, physical
activity, and social support) [15].
7.2. Implications for Research. In addition to exploring
changes in sleep disturbances between racial/ethnic groups,
the findings of this study may facilitate the development
of culturally appropriate, survivorship plans. The National
Comprehensive Cancer Network has recently developed
guidelines for survivorship care, specifically addressing sleep
disorders in cancer survivors. These guidelines can only be
generalizable if research is further conducted on minority
BCSs. Specifically, longitudinal studies should explore the
effect of physical symptoms, psychological symptoms, and
race/ethnicity on sleep disturbances. Without such studies,
survivorship care plans will be applicable to the white, nonHispanic population.
This study has several implications for research. Future
studies incorporating larger sample sizes with equal representation of white, non-Hispanic BCSs and minority BCSs
are needed. In addition, our findings indicate that the
relationship between symptoms and sleep disturbances are
different by races/ethnicities. Results suggest that depression
and fatigue are significant predictors of sleep disturbances
among minority BCSs and pain is a significant predictor of
sleep disturbances in white, non-Hispanic BCSs. Additional
research is needed to evaluate these relationships. Time since
completion of treatment did not differ by race/ethnicity, yet
this may be an important variable to be further examined in
relation to sleep disturbances in BCSs.
Furthermore, longitudinal studies are needed to examine the physical, emotional, and psychosocial contributing
factors to shortened TST in minority BCSs compared to
white, non-Hispanic BCSs [21]. Fewer hours of sleep has been
associated with higher recurrence scores and more aggressive
tumors in BCSs [57]. The association of shortened TST and
aggressive tumors in minority BCSs should also be further
explored. Longitudinal studies implementing longer periods
of wrist actigraphy are also required in this population [58].
This study focused on BCSs who remained disease-free after
treatment; it is essential that future research also incorporate
minority BCSs with recurrent and advanced cancer.
7.3. Implications for Nurses. The subjective and objective
assessment of sleep disturbances as part of survivorship care
for BCSs is ideal; however, objective assessments may not be
feasible in a clinical setting, indicating that practice guidelines
assessing sleep are essential. The National Comprehensive
Cancer Network (NCCN) guidelines for sleep disorders recommend screening cancer survivors at regular intervals [59].
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The following questions are recommended for screening: “do
you have difficulty falling or staying asleep,” “how long does
it take to fall asleep,” “how many times do you wake up every
night,” or “how long have you had difficulty in falling or
staying asleep?” If indicated after screening, nurses should
conduct comprehensive diagnostic exams including a sleeporiented history, physical examination, objective testing, and
education [60]. Routine assessment of sleep duration should
be completed at regular physical exams, specifically for
minority BCSs [23]. Inquiring about TST, by asking patients
“how many hours are you sleeping at night,” may be more
helpful in the identification of BCSs who are at a higher risk
of sleep disturbances. Assessments of depression, fatigue, and
pain should also be incorporated as part of routine sleep
assessment. Culturally appropriate questions during followup visits may reduce response bias associated with selfreports, particularly when assessing sleep disturbances and
depression in black BCSs [23].
Special consideration should be placed on sleep behaviors
among BCSs of different races/ethnicities with attention to
sleep hygiene practices, sleep partners, and use of sleep
medications. Blacks spend more time in bed without sleeping
compared to other ethnic groups and are more likely to report
performing activities in the hour before going to bed such
as watching TV or praying [46]. Alerting bedtime routines
may contribute to increased SOL among minority BCSs.
Secondly, a sleep partner could be a contributing factor to
sleep disturbances. Asians and Hispanics are more likely to
sleep in the same room with their children; whites are more
likely to sleep with their significant other; and blacks are most
likely to sleep alone [46]. Finally, the use of sleep medications
should be considered. Asians are least likely to take sleep
medications; whites are more likely to use over-the-counter
sleep aids; and blacks are more likely to take prescribed
medications.
Nurses are in an ideal position to assess, educate, develop,
and integrate evidence-based practice into the management
of sleep disturbances among BCSs. Clinical sleep assessments
should be a part of comprehensive assessment tools and
should be personalized towards minority BCSs. Education
provides nurses with the opportunity to teach BCSs about
techniques and interventions to manage sleep disturbances.
A previous study [61] documented that both black and
Hispanic women were not aware of resources for their
sleeping problems. Hence, BCSs with sleep disturbances
should be informed about interventions for the management
of their symptoms and should be encouraged to participate in
such interventions, which have been beneficial in addressing
symptoms associated with sleep disturbances, including pain,
fatigue, and depression [12]. In addition, oncology nurses
must collaboratively work with minority BCSs and their
families to incorporate sleep hygiene practices and generate
shared goals to improve sleep quality in BCSs. Financial
barriers, residential and social status, and access to followup care should be addressed as these factors may contribute
to increased depression and sleep disturbances in minority
BCSs [9, 53]. As required, referral to sleep specialists can also
be made [9, 59].
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8. Conclusion
The study’s findings suggest that minority BCSs have shorter
sleep durations compared to white, non-Hispanic BCSs. In
addition, pain, fatigue, and depression may be important
covariates of sleep disturbances in BCSs. We hypothesize
that race/ethnicity modified the association between physical/psychological symptoms and sleep disturbances. As part
of survivorship care, race/ethnicity should be included as an
essential component of comprehensive symptom assessments
in BCSs. Comprehensive sleep assessments including appropriate assessments of pain, fatigue, and depression should
be considered when developing and implementing patient
centered, culturally appropriate interventions.
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